| Line item | 2025-04-30 FY | 2024-04-30 FY | 2023-04-30 FY | 2022-04-30 FY | 2021-04-30 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $49.01K | $0.00 | $0.00 | $15.23K |
| Cost of Revenue | $0.00 | $24.41K | $0.00 | $0.00 | $13.09K |
| Gross Profit | $0.00 | $24.61K | $0.00 | – | – |
| Operating Expenses | $1.38M | $631.14K | $1.73M | $867.60K | $745.36K |
| R&D | – | – | – | – | – |
| SG&A | $747.28K | $174.69K | $285.30K | $360.94K | $313.20K |
| Operating Income | -$1.38M | -$606.54K | -$1.73M | -$867.60K | -$743.13K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$942.29K | -$575.77K | -$2.58M | -$675.62K | -$1.80M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | -0.0300 | -0.1000 | – | -2.2500 | -0.0400 |
| Shares (diluted) | $28.82M | $5.64M | – | $299.71K | $44.34M |